ClinicalTrials.govpublic full text
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1
human immunodeficiency virus (hiv), hiv infection, hiv-1, abbv-181, analytical treatment interruption, budigalimab, programmed cell death protein-1 (pd-1), anti-pd-1 antibody, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847283
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.